August 18th 2025
C difficile carriers faced a higher baseline risk for hospital-onset infection compared to non-carriers, and this risk was not significantly influenced by antibiotic use.
The Significance of Antimicrobial Stewardship in Dentistry
September 9th 2024Debra Goff, PharmD, discusses her advocacy around this topic and bringing the stewardship message to dentists about how antibiotic prescribing practices have changed and getting them to recalibrate their thinking and actions in their field.
Read More
Treatment Guidelines for C. difficile Infection
Experts on C. difficile infections give an overview of the ACG and IDSA/SHEA treatment guidelines for initial infection, first recurrence, and subsequent recurrences.
Watch
Diagnostic Tests for C. difficile Infections
Paul Feuerstadt, MD, FACG, AGAF, provides clinical insights on diagnostic testing practices for C. difficile infections, highlighting the EIA, GDH, and PCR assays.
Watch
Patients at Risk for Recurrent C. difficile Infections and the Role of Environmental Factors
Sahil Khanna, MBBS, MS, outlines patients at risk for recurrent C. difficile infections, and Teena Chopra, MD, MPH, FACP, FIDSA, FSHEA, focuses on environmental considerations that can help prevent transmission.
Watch
Risk Factors for C. difficile Infections
Carl V. Crawford, MD, outlines the risk factors for C. difficile infections, focusing on factors that affect the body’s microbiome or immune system, including antibiotics, age, comorbid conditions, exposures, and prior C. difficile infections.
Watch
Top 5 Infectious Disease News Stories Week of August 23-August 30
August 31st 2024This week, MP Biomedicals launched rapid diagnostic tests for gastrointestinal pathogens, Invivyd's monoclonal antibody pemivibart shows an 84% reduction in symptomatic COVID-19 risk, Nestlé is acquiring global rights to the Vowst therapy for CDI, and more.
Read More
Recurrence of C. Difficile Infections
Teena Chopra, MD, MPH, FACP, FIDSA, FSHEA, and Matthew D. Sims, MD, PhD, FACP, FIDSA, provide clinical insights on the rate of recurrence of C. difficile infections and the impact on patients.
Watch
Epidemiology of C. difficile Infections in the US
A panel of experts provide an overview of the epidemiology of Clostridioides difficile infections, highlighting diagnostic practices and the role of antimicrobial stewardship.
Watch
The Benefits of Making C diff a Nationally Notifiable Infectious Disease
August 26th 2024In the second part of our interview with Christian Lillis, cofounder and CEO of the Peggy Lillis Foundation, he discusses what the passage of the Peggy Lillis Clostridioides difficile Inclusion Act would do for reporting of the infection as well as the potential ancillary effects around antibiotic development and antimicrobial resistance.
Watch
Updated Details on Vedanta's Phase 3 VE303 Trial for Recurrent C difficile
August 14th 2024Jeffery Silber MD, highlights VE303's consistent formulation as an advantage over traditional fecal transplants and discusses how the trial's patient-centric approach aims to improve outcomes and reduce healthcare-associated infections.
Read More
The Genesis of C diff Advocacy
August 13th 2024Peggy Lillis Foundation CEO Christian Lillis talks about how he became involved in advocacy around C diff and his motivation in helping to bring a bill to Congress to make the healthcare-associated infection a nationally notifiable infectious disease and condition.
Watch
Top 5 Infectious Disease News Stories: Week of August 2-August 9
August 10th 2024Enhanced diagnostic and surveillance measures for hypervirulent pathogens, new CDC safety data on RSV vaccines showing rare risks, updated IDSA guidance for managing antimicrobial-resistant infections, and more this week from Contagion.
Read More
Top 5 Infectious Disease News Stories Week of July 13-July 19
July 20th 2024This week, the resurgence of leptospirosis in Wyoming, insights on COVID-19 reinfection severity, avian influenza cases in the US, challenges in medical communication amid scientific advancements, recent FDA recalls, and more from Contagion.
Read More
Insights from Recent Studies on Advancements in C difficile Treatment and Management
June 28th 2024DDW 2024 highlighted advances in managing recurrent C difficile infections, emphasis on the effectiveness of live biotherapeutic products and the impact of antibiotic stewardship, and more ongoing efforts in combating C difficile.
Read More
Top 5 Infectious Disease News Stories Week of June 21-June 28
June 28th 2024The FDA recalls ice cream, orzo, and mixed nuts. Also this week, interviews with Jared Baeten, MD, PhD, on Lenacapavir's 100% efficacy against HIV, and Jason Roberts, PhD, on the promise of continuous β-Lactam against sepsis, and more from Contagion.
Read More
Navigating Dual Infections: Managing Helicobacter pylori and C difficile
June 26th 2024A case study of an 80-year-old patient, illustrating successful management of dual H pylori and C diff infections with quadruple therapy, with key insights from Yazan Abboud, MD and Sima Vossough-Teehan, MD.
Read More
Efficacy of Fecal Microbiota Transplantation for Initial C difficile Infection
June 25th 2024Researchers assess the efficacy of fecal microbiota transplantation (FMT) for first or second episodes of Cdifficile infection (CDI), demonstrating high initial cure rates and sustained in managing the condition.
Read More
Top 5 Infectious Disease News Stories Week of June 15-June 21
June 21st 2024FDA approves pneumococcal vaccine V116, Salmonella outbreak linked to a household pet, Japan is currently facing an unprecedented surge in cases of streptococcal toxic shock syndrome, and more this week from Contagion.
Read More